TY - JOUR T1 - Possible fates of the dispersion of SARS-COV-2 in the Mexican context JF - medRxiv DO - 10.1101/2020.07.15.20154526 SP - 2020.07.15.20154526 AU - I. Santamaría-Holek AU - V. Castaño Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/30/2020.07.15.20154526.abstract N2 - The determination of the adequate time for house confinement and when social distancing restrictions should end are now two of the main challenges that any country has to face in an effective battle against. The possibility of a new outbreak of the pandemic and how to avoid it is, nowadays, one of the primary objectives of epidemiological research. In this work, we go deep in this subject by presenting an innovative compartmental model, that explicitly introduces the number of active cases, and employing it as a conceptual tool to explore the possible fates of the dispersion of SARS-COV-2 in the Mexican context. We incorporated the impact of starting, inattention, and end of restrictive social policies on the time evolution of the pandemics via time-in-run corrections to the infection rates. The magnitude and impact on the epidemic due to post-social restrictive policies are also studied. The scenarios generated by the model can help authorities to determine an adequate time and population load that may be allowed to reassume normal activities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by UNAM-DGAPA under grant IN117419. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No patients were involved in this research that used public data on the evolution of the pandemics in Mexico, particularly the official numbers of accumulated confirmed cases, recovered patients, and the number of deaths.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSupplementary material from "Possible fates of the dispersion of SARS-COV-2 in the Mexican context" submitted with DOI https://doi.org/10.5061/dryad.70rxwdbv5. All epidemiological data were taken from https://es.wikipedia.org/wiki/Pandemia_de_enfermedad_por_coronavirus_de_2020_en_Mexico which summarizes data from https://coronavirus.gob.mx/datos/ ER -